TNFSF10 and neoplasm: While loss-of-function studies have provided important information revealing accelerated tumor formation in TRAIL-deficient mice and thereby confirmed its implication in tumor defense, the corresponding in vivo gain-of-function analysis demonstrating protection against tumorigenesis by increasing endogenous TRAIL levels in the animal or a given tissue has not yet been done.